Daniel H Jo, MD
Rheumatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Offices
- 2
Offices
2 locations · South Bay Medical Associates Inc · 2 clinicians in this group
Hospitals listed: B21550 · El Camino Health · 555524. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$530,066
Medicare paid this office $530,066 for 197 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, inclisiran, 1 mg | 20 | $86,490 | None |
| Injection, denosumab, 1 mg | 26 | $53,329 | None |
| Return visit (30+ min) | 112 | $35,337 | $115 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 26 | $21,996 | $99 |
| Administration of chemotherapy into vein, 1 hour or less | 18 | $12,742 | $134 |
See all 9 services
| Injection, inclisiran, 1 mg | 20 | $86,490 | None |
| Injection, denosumab, 1 mg | 26 | $53,329 | None |
| Return visit (30+ min) | 112 | $35,337 | $115 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 26 | $21,996 | $99 |
| Administration of chemotherapy into vein, 1 hour or less | 18 | $12,742 | $134 |
| New patient visit (45+ min) | 49 | $7,327 | $150 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 50 | $7,280 | $72 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 24 | $3,991 | $166 |
| Long return visit (40+ min) | 15 | $2,746 | $137 |
Who their Medicare patients are
197 Original Medicare patients in 2024. Average age 78 · Women 70% · Also on Medicaid 13% · Health risk score 1.22. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Coronary heart disease 37% · Diabetes 32% · Atrial fibrillation 25% · Heart failure 24% · Chronic kidney disease 20% · Depression 20% · Cancer 16% · Dementia 15% · Stroke 15% · COPD 14%.
The office billed $1,285,034, Medicare allowed $666,898 and paid $530,066; for 41,576 services of 49 kinds; $421,757 of it was for drugs given in the office and $108,309 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 197 | 41,576 | 78 | 1.22 | $1,285,034 | $530,066 |
| 2023 | 272 | 34,618 | 79 | 1.62 | $1,661,602 | $681,390 |
| 2022 | 471 | 25,783 | 82 | 1.93 | $2,688,521 | $1,060,448 |
| 2021 | 515 | 14,435 | 81 | 1.92 | $1,034,666 | $374,527 |
| 2020 | 378 | 3,561 | 80 | 2.08 | $547,678 | $188,615 |
| 2019 | 411 | 1,529 | 78 | 2.61 | $454,862 | $142,197 |
| 2018 | 436 | 1,322 | 76 | 2.69 | $563,251 | $123,917 |
| 2017 | 182 | 449 | 77 | 2.55 | $203,051 | $43,017 |
| 2016 | 129 | 221 | 79 | 2.80 | $85,900 | $21,891 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Injection, inclisiran, 1 mg | 21 | $72,334 | None |
| Injection, denosumab, 1 mg | 22 | $40,085 | None |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 73 | $32,131 | $96 |
| Return visit (30+ min) | 107 | $30,846 | $116 |
| Administration of chemotherapy into vein, 1 hour or less | 17 | $13,617 | $142 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 61 | $11,148 | $162 |
| New patient visit (45+ min) | 56 | $7,667 | $137 |
| Nursing facility discharge management, more than 30 minutes | 58 | $7,100 | $116 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 46 | $6,769 | $78 |
| New patient visit (60+ min) | 27 | $5,258 | $195 |
| Long return visit (40+ min) | 15 | $3,081 | $162 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 18 | $3,035 | $65 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 22 | $2,930 | $122 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $679 | $49 |
2022: 20 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 247 | $105,356 | $82 |
| Injection, romosozumab-aqqg, 1 mg | 11 | $100,415 | None |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 225 | $38,798 | $147 |
| Injection, denosumab, 1 mg | 23 | $33,250 | None |
| Return visit (30+ min) | 99 | $31,511 | $112 |
| Nursing facility discharge management, more than 30 minutes | 168 | $17,237 | $93 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 57 | $11,077 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $8,147 | $95 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 19 | $7,112 | $109 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 14 | $6,802 | $158 |
| New patient visit (45+ min) | 49 | $6,761 | $138 |
| New patient visit (60+ min) | 30 | $6,247 | $208 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 43 | $5,191 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,851 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $2,589 | $66 |
| Long return visit (40+ min) | 11 | $2,512 | $167 |
| Injection of drug or substance under skin or into muscle | 27 | $2,061 | $14 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 16 | $1,993 | $117 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 27 | $1,818 | $52 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $1,059 | $81 |
2021: 19 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 224 | $76,337 | $84 |
| Injection, romosozumab-aqqg, 1 mg | 11 | $72,637 | None |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 284 | $47,643 | $151 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 176 | $40,536 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 86 | $18,967 | $97 |
| Nursing facility discharge management, more than 30 minutes | 172 | $17,872 | $97 |
| Return visit (30+ min) | 51 | $14,281 | $124 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,764 | $184 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 22 | $7,745 | $109 |
| New patient visit (45+ min) | 35 | $5,375 | $154 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,803 | $104 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $2,783 | $127 |
| New patient visit (60+ min) | 13 | $2,568 | $198 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $2,484 | $86 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 33 | $1,780 | $52 |
| Injection of drug or substance under skin or into muscle | 17 | $1,419 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,287 | $76 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 11 | $986 | $62 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 13 | $908 | $41 |
2020: 13 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 115 | $49,150 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 165 | $43,179 | $96 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 113 | $18,538 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $12,418 | $183 |
| Nursing facility discharge management, more than 30 minutes | 74 | $7,754 | $96 |
| Hospital discharge day management, more than 30 minutes | 69 | $6,947 | $101 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 14 | $6,073 | $127 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 31 | $5,325 | $57 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 11 | $3,796 | $181 |
| Return visit (30+ min) | 15 | $2,996 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,758 | $68 |
| Advance care planning, first 30 minutes | 14 | $1,157 | $72 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 17 | $1,044 | $52 |
2019: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 177 | $39,481 | $86 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 98 | $30,557 | $78 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 112 | $17,408 | $142 |
| Hospital discharge day management, more than 30 minutes | 119 | $12,031 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,642 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $7,090 | $64 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 29 | $6,183 | $119 |
| Nursing facility discharge management, more than 30 minutes | 54 | $5,388 | $96 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $3,129 | $64 |
| Follow-up observation care per day, typically 35 minutes | 17 | $2,069 | $94 |
| Hospital observation care on day of discharge | 24 | $1,531 | $64 |
| Advance care planning, first 30 minutes | 14 | $1,070 | $71 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 281 | $62,597 | $93 |
| Hospital discharge day management, more than 30 minutes | 197 | $20,293 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 107 | $14,708 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,533 | $182 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 13 | $3,600 | $116 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 16 | $3,214 | $78 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 20 | $2,890 | $144 |
| Hospital observation care on day of discharge | 29 | $1,939 | $67 |
| Follow-up observation care per day, typically 35 minutes | 14 | $1,231 | $88 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 119 | $22,296 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,458 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $5,488 | $65 |
| Hospital discharge day management, more than 30 minutes | 53 | $5,302 | $98 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $15,147 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,612 | $181 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,143 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $957 | $64 |
Medicaid work
$278 in 2022
Medicaid paid $278 for 23 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 23 | $278 |
| 2022 | 23 | 1 | 12 | $278 |
| 2021 | 25 | 1 | 12 | $609 |
| 2020 | 20 | 1 | 13 | $339 |
| 2019 | 232 | 2 | 21 | $3,279 |
| 2018 | 530 | 2 | 28 | $9,903 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $609 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 20 | $339 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 189 | $2,409 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 43 | $870 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 403 | $7,041 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 127 | $2,862 |
Drugs they prescribed that Part D paid
$525,100
Pharmacies billed $525,100 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (19 of 1,143) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
997 generic and fewer than 11 brand-name prescriptions · $525,100 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 22 | $12,782 | $581 |
| Duloxetine | 16 | $2,307 | $144 |
| Hydroxychloroquine Sulfate | 57 | $2,108 | $37 |
| Methotrexate | 76 | $1,500 | $20 |
| Leflunomide | 22 | $1,323 | $60 |
See all 29 drugs
| Eliquis | 22 | $12,782 | $581 |
| Duloxetine | 16 | $2,307 | $144 |
| Hydroxychloroquine Sulfate | 57 | $2,108 | $37 |
| Methotrexate | 76 | $1,500 | $20 |
| Leflunomide | 22 | $1,323 | $60 |
| Memantine | 24 | $955 | $40 |
| Levothyroxine | 61 | $755 | $12 |
| Sertraline | 32 | $514 | $16 |
| Amlodipine Besylate | 61 | $495 | $8 |
| Alendronate | 33 | $476 | $14 |
| Atorvastatin | 40 | $451 | $11 |
| Omeprazole | 30 | $433 | $14 |
| Allopurinol | 18 | $382 | $21 |
| Ondansetron Odt | 11 | $368 | $33 |
| Prednisone | 64 | $344 | $5 |
| Tamsulosin | 24 | $294 | $12 |
| Gabapentin | 23 | $272 | $12 |
| Losartan | 20 | $272 | $14 |
| Folic Acid | 14 | $215 | $15 |
| Albuterol Sulfate Hfa | 11 | $212 | $19 |
| Pantoprazole | 13 | $197 | $15 |
| Lisinopril | 12 | $187 | $16 |
| Metoprolol | 11 | $187 | $17 |
| Dexamethasone | 18 | $179 | $10 |
| Hydrocodone-Acetaminophen | 12 | $178 | $15 |
| Metformin | 20 | $145 | $7 |
| Latanoprost | 11 | $128 | $12 |
| Clopidogrel | 20 | $119 | $6 |
| Alprazolam | 14 | $75 | $5 |
Year by year
| 2024 | 1,143 | 130 | 2% (19) | None | $525,100 |
| 2023 | 1,727 | 146 | 2% (35) | None | $366,708 |
| 2022 | 3,164 | 270 | 3% (90) | None | $379,999 |
| 2021 | 3,743 | 289 | 4% (156) | None | $330,049 |
| 2020 | 2,421 | 171 | 3% (74) | None | $142,135 |
| 2019 | 1,091 | 153 | 4% (41) | None | $52,728 |
| 2018 | 416 | 177 | 6% (24) | None | $83,445 |
| 2017 | 92 | 64 | 19% (17) | 18% | $16,160 |
| 2016 | 116 | 42 | None | 24% | $64,897 |
| 2015 | 183 | 46 | None | 25% | $72,645 |
| 2014 | 65 | 19 | None | 28% | $7,265 |
| 2013 | 81 | 21 | None | 28% | $5,698 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 47 drugs
| Enbrel Mini | 11 | $84,687 | $7,699 |
| Forteo | 17 | $67,694 | $3,982 |
| Tymlos | 16 | $43,526 | $2,720 |
| Eliquis | 58 | $31,461 | $542 |
| Symbicort | 12 | $4,866 | $405 |
| Duloxetine | 37 | $4,230 | $114 |
| Methotrexate | 90 | $3,288 | $37 |
| Jardiance | 11 | $3,127 | $284 |
| Hydroxychloroquine Sulfate | 49 | $2,594 | $53 |
| Leflunomide | 17 | $2,589 | $152 |
| Levothyroxine | 100 | $1,612 | $16 |
| Gabapentin | 50 | $1,596 | $32 |
| Mycophenolate Mofetil | 13 | $1,123 | $86 |
| Eplerenone | 11 | $1,047 | $95 |
| Prednisone | 95 | $1,024 | $11 |
| Sertraline | 67 | $966 | $14 |
| Atorvastatin | 53 | $874 | $16 |
| Amlodipine Besylate | 91 | $767 | $8 |
| Levetiracetam | 18 | $708 | $39 |
| Hydrocodone-Acetaminophen | 19 | $623 | $33 |
| Metoprolol | 27 | $585 | $22 |
| Memantine | 26 | $560 | $22 |
| Omeprazole | 59 | $549 | $9 |
| Divalproex | 17 | $484 | $28 |
| Cephalexin | 17 | $443 | $26 |
| Alendronate | 22 | $421 | $19 |
| Allopurinol | 19 | $387 | $20 |
| Losartan | 40 | $376 | $9 |
| Tamsulosin | 25 | $373 | $15 |
| Ondansetron Odt | 14 | $362 | $26 |
| Metformin | 27 | $361 | $13 |
| Nystatin | 11 | $357 | $32 |
| Pantoprazole | 35 | $294 | $8 |
| Sulfasalazine | 15 | $278 | $19 |
| Clopidogrel | 15 | $232 | $15 |
| Lisinopril | 19 | $209 | $11 |
| Dexamethasone | 18 | $209 | $12 |
| Hydroxyurea | 12 | $164 | $14 |
| Trazodone | 15 | $138 | $9 |
| Donepezil | 26 | $133 | $5 |
| Ibuprofen | 12 | $124 | $10 |
| Metoprolol | 19 | $116 | $6 |
| Hydrochlorothiazide | 12 | $115 | $10 |
| Citalopram Hbr | 21 | $113 | $5 |
| Montelukast | 14 | $111 | $8 |
| Latanoprost | 15 | $108 | $7 |
| Furosemide | 15 | $96 | $6 |
2022: 71 drugs
| Forteo | 26 | $105,049 | $4,040 |
| Eliquis | 130 | $45,902 | $353 |
| Xifaxan | 14 | $44,800 | $3,200 |
| Myrbetriq | 41 | $16,393 | $400 |
| Duloxetine | 54 | $6,000 | $111 |
| Tradjenta | 22 | $5,336 | $243 |
| Xarelto | 17 | $4,922 | $290 |
| Lantus | 13 | $3,927 | $302 |
| Breo Ellipta | 15 | $3,914 | $261 |
| Brinzolamide | 11 | $3,058 | $278 |
| Aripiprazole | 11 | $2,858 | $260 |
| Leflunomide | 14 | $2,552 | $182 |
| Gabapentin | 85 | $2,082 | $24 |
| Divalproex | 37 | $1,901 | $51 |
| Methotrexate | 36 | $1,868 | $52 |
| Levothyroxine | 150 | $1,860 | $12 |
| Hydroxychloroquine Sulfate | 31 | $1,830 | $59 |
| Donepezil | 73 | $1,704 | $23 |
| Atorvastatin | 123 | $1,601 | $13 |
| Potassium Chloride | 43 | $1,382 | $32 |
| Carbidopa-Levodopa | 34 | $1,305 | $38 |
| Methenamine Hippurate | 11 | $1,078 | $98 |
| Amlodipine Besylate | 134 | $1,059 | $8 |
| Memantine | 50 | $964 | $19 |
| Celecoxib | 14 | $959 | $69 |
| Colchicine | 12 | $907 | $76 |
| Oxycodone-Acetaminophen | 20 | $894 | $45 |
| Pantoprazole | 61 | $872 | $14 |
| Albuterol Sulfate Hfa | 15 | $811 | $54 |
| Sertraline | 69 | $761 | $11 |
| Metoprolol | 47 | $746 | $16 |
| Prednisone | 71 | $740 | $10 |
| Omeprazole | 61 | $703 | $12 |
| Carbidopa-Levodopa Er | 11 | $690 | $63 |
| Latanoprost | 39 | $667 | $17 |
| Losartan | 54 | $564 | $10 |
| Tamsulosin | 43 | $518 | $12 |
| Methocarbamol | 13 | $510 | $39 |
| Nystatin | 13 | $415 | $32 |
| Hydrocodone-Acetaminophen | 21 | $408 | $19 |
| Furosemide | 87 | $383 | $4 |
| Metoprolol | 59 | $376 | $6 |
| Alendronate | 15 | $355 | $24 |
| Cephalexin | 40 | $346 | $9 |
| Mirtazapine | 17 | $333 | $20 |
| Brimonidine | 25 | $328 | $13 |
| Hydrocortisone | 12 | $311 | $26 |
| Trazodone | 36 | $308 | $9 |
| Metformin | 43 | $288 | $7 |
| Escitalopram | 36 | $278 | $8 |
| Clopidogrel | 26 | $260 | $10 |
| Lisinopril | 24 | $239 | $10 |
| Famotidine | 26 | $230 | $9 |
| Hydrochlorothiazide | 20 | $226 | $11 |
| Allopurinol | 30 | $223 | $7 |
| Quetiapine | 14 | $218 | $16 |
| Spironolactone | 18 | $216 | $12 |
| Ondansetron | 12 | $199 | $17 |
| Carvedilol | 27 | $183 | $7 |
| Lorazepam | 16 | $175 | $11 |
| Rosuvastatin | 12 | $169 | $14 |
| Pregabalin | 11 | $169 | $15 |
| Tramadol | 11 | $134 | $12 |
| Timolol Maleate | 12 | $133 | $11 |
| Metolazone | 12 | $122 | $10 |
| Morphine Sulfate | 15 | $119 | $8 |
| Triamcinolone Acetonide | 13 | $110 | $8 |
| Citalopram Hbr | 24 | $95 | $4 |
| Folic Acid | 16 | $60 | $4 |
| Alprazolam | 12 | $35 | $3 |
| Ciprofloxacin | 12 | $31 | $3 |
2021: 81 drugs
| Eliquis | 138 | $46,763 | $339 |
| Myrbetriq | 58 | $22,061 | $380 |
| Xtampza Er | 40 | $8,756 | $219 |
| Lantus | 25 | $7,624 | $305 |
| Novolog | 21 | $6,525 | $311 |
| Breo Ellipta | 22 | $6,322 | $287 |
| Aripiprazole | 43 | $5,941 | $138 |
| Xarelto | 18 | $4,376 | $243 |
| Duloxetine | 47 | $3,919 | $83 |
| Enoxaparin | 21 | $3,440 | $164 |
| Colchicine | 31 | $3,241 | $105 |
| Potassium Chloride | 46 | $2,554 | $56 |
| Gabapentin | 100 | $2,148 | $21 |
| Divalproex | 38 | $1,950 | $51 |
| Atorvastatin | 140 | $1,838 | $13 |
| Donepezil | 75 | $1,779 | $24 |
| Levothyroxine | 143 | $1,743 | $12 |
| Memantine | 66 | $1,682 | $25 |
| Nystop | 37 | $1,657 | $45 |
| Pantoprazole | 74 | $1,505 | $20 |
| Memantine Hcl Er | 12 | $1,371 | $114 |
| Mirtazapine | 53 | $1,352 | $26 |
| Methenamine Hippurate | 11 | $1,057 | $96 |
| Amlodipine Besylate | 145 | $1,036 | $7 |
| Latanoprost | 33 | $969 | $29 |
| Baclofen | 53 | $922 | $17 |
| Lactulose | 24 | $906 | $38 |
| Hydrocodone-Acetaminophen | 44 | $877 | $20 |
| Losartan | 71 | $833 | $12 |
| Oxycodone-Acetaminophen | 25 | $781 | $31 |
| Metformin | 84 | $766 | $9 |
| Furosemide | 137 | $748 | $5 |
| Carbidopa-Levodopa | 12 | $689 | $57 |
| Metoprolol | 48 | $679 | $14 |
| Metoprolol | 78 | $677 | $9 |
| Tamsulosin | 37 | $591 | $16 |
| Diltiazem 24hr Er (Cd) | 18 | $579 | $32 |
| Omeprazole | 55 | $558 | $10 |
| Rosuvastatin | 12 | $481 | $40 |
| Clopidogrel | 35 | $467 | $13 |
| Ezetimibe | 11 | $435 | $40 |
| Bupropion Xl | 20 | $414 | $21 |
| Hydroxyzine | 30 | $392 | $13 |
| Escitalopram | 48 | $378 | $8 |
| Lisinopril | 35 | $349 | $10 |
| Methocarbamol | 17 | $349 | $21 |
| Trazodone | 51 | $348 | $7 |
| Alendronate | 30 | $348 | $12 |
| Prednisone | 44 | $342 | $8 |
| Quetiapine | 17 | $332 | $20 |
| Ondansetron | 16 | $329 | $21 |
| Allopurinol | 39 | $327 | $8 |
| Bupropion Hcl Sr | 14 | $321 | $23 |
| Famotidine | 27 | $320 | $12 |
| Hydroxychloroquine Sulfate | 16 | $319 | $20 |
| Propranolol | 19 | $315 | $17 |
| Amiodarone | 13 | $302 | $23 |
| Sertraline | 29 | $285 | $10 |
| Fluticasone Propionate | 15 | $281 | $19 |
| Spironolactone | 28 | $274 | $10 |
| Cephalexin | 30 | $267 | $9 |
| Hydralazine | 21 | $265 | $13 |
| Dexamethasone | 24 | $249 | $10 |
| Paroxetine | 18 | $226 | $13 |
| Hydrocortisone | 13 | $211 | $16 |
| Warfarin | 36 | $208 | $6 |
| Metolazone | 24 | $189 | $8 |
| Triamcinolone Acetonide | 15 | $188 | $13 |
| Topiramate | 20 | $182 | $9 |
| Oxycodone | 16 | $179 | $11 |
| Carvedilol | 20 | $173 | $9 |
| Ciprofloxacin | 13 | $164 | $13 |
| Citalopram Hbr | 24 | $145 | $6 |
| Simvastatin | 22 | $143 | $6 |
| Tramadol | 20 | $120 | $6 |
| Hydrochlorothiazide | 14 | $114 | $8 |
| Timolol Maleate | 11 | $113 | $10 |
| Isosorbide Mononitrate Er | 11 | $109 | $10 |
| Glipizide | 16 | $106 | $7 |
| Atenolol | 19 | $106 | $6 |
| Brimonidine | 11 | $95 | $9 |
2020: 64 drugs
| Eliquis | 95 | $28,103 | $296 |
| Myrbetriq | 39 | $9,363 | $240 |
| Lantus | 30 | $9,137 | $305 |
| Breo Ellipta | 35 | $6,624 | $189 |
| Xarelto | 25 | $6,000 | $240 |
| Spiriva | 11 | $5,112 | $465 |
| Aripiprazole | 28 | $4,464 | $159 |
| Memantine | 29 | $2,760 | $95 |
| Colchicine | 26 | $2,651 | $102 |
| Divalproex | 35 | $2,212 | $63 |
| Memantine Hcl Er | 12 | $2,206 | $184 |
| Duloxetine | 23 | $1,886 | $82 |
| Lamotrigine Er | 11 | $1,656 | $151 |
| Gabapentin | 93 | $1,624 | $17 |
| Donepezil | 45 | $1,610 | $36 |
| Baclofen | 53 | $1,284 | $24 |
| Atorvastatin | 93 | $1,179 | $13 |
| Lidocaine | 11 | $1,156 | $105 |
| Potassium Chloride | 33 | $915 | $28 |
| Pantoprazole | 65 | $794 | $12 |
| Hydrocodone-Acetaminophen | 26 | $775 | $30 |
| Levothyroxine | 62 | $754 | $12 |
| Tamsulosin | 33 | $710 | $22 |
| Furosemide | 112 | $669 | $6 |
| Mirtazapine | 22 | $593 | $27 |
| Losartan | 35 | $586 | $17 |
| Digoxin | 19 | $546 | $29 |
| Amantadine | 13 | $508 | $39 |
| Carbidopa-Levodopa | 21 | $490 | $23 |
| Bupropion Hcl Sr | 19 | $477 | $25 |
| Bupropion Xl | 15 | $462 | $31 |
| Quetiapine | 15 | $457 | $30 |
| Amlodipine Besylate | 76 | $436 | $6 |
| Simvastatin | 34 | $435 | $13 |
| Omeprazole | 33 | $421 | $13 |
| Lactulose | 15 | $404 | $27 |
| Prednisone | 45 | $401 | $9 |
| Topiramate | 26 | $386 | $15 |
| Trazodone | 38 | $380 | $10 |
| Oxycodone | 19 | $367 | $19 |
| Ondansetron | 19 | $359 | $19 |
| Clopidogrel | 18 | $345 | $19 |
| Metoprolol | 37 | $327 | $9 |
| Latanoprost | 14 | $314 | $22 |
| Hydralazine | 18 | $292 | $16 |
| Metoprolol | 20 | $250 | $13 |
| Sertraline | 27 | $245 | $9 |
| Ropinirole | 11 | $241 | $22 |
| Metolazone | 24 | $238 | $10 |
| Propranolol | 15 | $221 | $15 |
| Levetiracetam | 12 | $218 | $18 |
| Hydroxyzine | 18 | $212 | $12 |
| Lisinopril | 26 | $201 | $8 |
| Finasteride | 17 | $194 | $11 |
| Metformin | 24 | $186 | $8 |
| Ciprofloxacin | 20 | $182 | $9 |
| Escitalopram | 22 | $179 | $8 |
| Cephalexin | 28 | $177 | $6 |
| Spironolactone | 20 | $167 | $8 |
| Alendronate | 15 | $160 | $11 |
| Allopurinol | 11 | $91 | $8 |
| Triamcinolone Acetonide | 12 | $79 | $7 |
| Warfarin | 13 | $51 | $4 |
| Atenolol | 13 | $38 | $3 |
2019: 29 drugs
| Eliquis | 32 | $8,656 | $271 |
| Spiriva | 12 | $5,728 | $477 |
| Breo Ellipta | 30 | $5,043 | $168 |
| Tamsulosin | 36 | $935 | $26 |
| Atorvastatin | 51 | $747 | $15 |
| Potassium Chloride | 27 | $635 | $24 |
| Gabapentin | 40 | $564 | $14 |
| Metoprolol | 22 | $544 | $25 |
| Pantoprazole | 35 | $541 | $15 |
| Hydralazine | 19 | $426 | $22 |
| Furosemide | 53 | $402 | $8 |
| Ethambutol | 12 | $337 | $28 |
| Mirtazapine | 15 | $315 | $21 |
| Isosorbide Mononitrate Er | 18 | $296 | $16 |
| Bupropion Xl | 13 | $278 | $21 |
| Hydrocodone-Acetaminophen | 12 | $258 | $21 |
| Ondansetron | 13 | $207 | $16 |
| Oxycodone | 13 | $200 | $15 |
| Doxycycline Hyclate | 18 | $178 | $10 |
| Simvastatin | 25 | $171 | $7 |
| Levothyroxine | 21 | $161 | $8 |
| Prednisone | 18 | $139 | $8 |
| Losartan | 16 | $135 | $8 |
| Metoprolol | 21 | $118 | $6 |
| Methimazole | 11 | $115 | $10 |
| Amlodipine Besylate | 20 | $92 | $5 |
| Finasteride | 12 | $86 | $7 |
| Lisinopril | 12 | $83 | $7 |
| Warfarin | 15 | $79 | $5 |
2018: 7 drugs
| Lyrica | 11 | $5,832 | $530 |
| Hydroxychloroquine Sulfate | 27 | $4,202 | $156 |
| Methotrexate | 14 | $471 | $34 |
| Prednisone | 22 | $306 | $14 |
| Sulfasalazine | 13 | $301 | $23 |
| Furosemide | 15 | $77 | $5 |
| Amlodipine Besylate | 13 | $70 | $5 |
2016: 2 drugs
| Methotrexate | 20 | $1,808 | $90 |
| Prednisone | 19 | $262 | $14 |
2015: 3 drugs
| Hydroxychloroquine Sulfate | 20 | $3,499 | $175 |
| Methotrexate | 24 | $1,924 | $80 |
| Prednisone | 34 | $390 | $11 |
2014: 1 drug
| Prednisone | 16 | $189 | $12 |
Money from drug and device companies
$2,430 in 2025
| 2025 | 19 | 95 | None | $2,430 |
| 2024 | 15 | 184 | None | $3,909 |
| 2023 | 18 | 120 | None | $3,085 |
| 2022 | 11 | 62 | None | $1,545 |
| 2021 | 12 | 32 | None | $849 |
| 2020 | 2 | 4 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Krystexxa | $549 | 25 payments
|
| Janssen Biotech | Tremfya | $347 | 8 payments
|
| GlaxoSmithKline | Benlysta | $301 | 14 payments
|
| Radius Health | Tymlos | $208 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $159 | 8 payments
|
| Ucb | Bimzelx | $153 | 7 payments
|
See all 95 published payments
| Lumenis BE | Meals · 2025-12-22 | M22 | $136 |
| Amgen | Meals · 2025-12-22 | Tavneos | $17 |
| Novartis Pharmaceuticals | Meals · 2025-12-15 | Cosentyx | $21 |
| GlaxoSmithKline | Meals · 2025-12-08 | Benlysta | $23 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $14 |
| Novartis Pharmaceuticals | Meals · 2025-11-19 | Cosentyx | $23 |
| Amgen | Meals · 2025-11-17 | Evenity | $37 |
| GlaxoSmithKline | Meals · 2025-11-13 | Benlysta | $27 |
| Merz North America | Meals · 2025-11-13 | None | $14 |
| Janssen Biotech | Meals · 2025-11-11 | Tremfya | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-29 | Saphnelo | $26 |
| Janssen Biotech | Meals · 2025-10-28 | Tremfya | $37 |
| Janssen Biotech | Meals · 2025-10-28 | Tremfya | $8 |
| Ucb | Meals · 2025-10-27 | Bimzelx | $25 |
| Radius Health | Meals · 2025-10-17 | Tymlos | $15 |
| Novartis Pharmaceuticals | Meals · 2025-10-13 | Cosentyx | $19 |
| Abbvie | Meals · 2025-10-10 | Rinvoq | $30 |
| Radius Health | Meals · 2025-10-09 | Tymlos | $123 |
| Amgen | Meals · 2025-10-07 | Evenity | $36 |
| GlaxoSmithKline | Meals · 2025-09-30 | Benlysta | $18 |
| Amgen | Meals · 2025-09-30 | Tavneos | $26 |
| Amgen | Meals · 2025-09-22 | Otezla | $6 |
| Amgen | Meals · 2025-09-10 | Krystexxa | $11 |
| GlaxoSmithKline | Meals · 2025-08-28 | Benlysta | $20 |
| Radius Health | Meals · 2025-08-19 | Tymlos | $19 |
| GlaxoSmithKline | Meals · 2025-08-13 | Benlysta | $18 |
| Revance Therapeutics | Meals · 2025-08-12 | None | $22 |
| Amgen | Meals · 2025-08-07 | Evenity | $22 |
| Merz North America | Meals · 2025-08-05 | None | $16 |
| Pfizer | Meals · 2025-08-04 | Xeljanz | $24 |
| Amgen | Meals · 2025-08-01 | Tavneos | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-30 | Saphnelo | $20 |
| Janssen Biotech | Meals · 2025-07-28 | Tremfya | $25 |
| Mallinckrodt Hospital Products | Meals · 2025-07-22 | Acthar | $28 |
| Ucb | Meals · 2025-07-21 | Bimzelx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-07-14 | Cosentyx | $19 |
| Amgen | Meals · 2025-07-14 | Otezla | $7 |
| GlaxoSmithKline | Meals · 2025-07-10 | Benlysta | $21 |
| GlaxoSmithKline | Meals · 2025-06-26 | Benlysta | $24 |
| Janssen Biotech | Education · 2025-06-17 | Tremfya | $100 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-17 | Saphnelo | $19 |
| Amgen | Meals · 2025-06-16 | Evenity | $30 |
| Amgen | Meals · 2025-06-12 | Otezla | $7 |
| Radius Health | Meals · 2025-06-12 | Tymlos | $27 |
| Ucb | Meals · 2025-06-11 | Bimzelx | $8 |
| Amgen | Meals · 2025-06-10 | Krystexxa | $11 |
| Pfizer | Meals · 2025-06-09 | Xeljanz | $25 |
| Novartis Pharmaceuticals | Meals · 2025-06-04 | Cosentyx | $19 |
| Abbvie | Meals · 2025-06-04 | Skyrizi | $23 |
| Amgen | Meals · 2025-05-29 | Otezla | $8 |
| GlaxoSmithKline | Meals · 2025-05-27 | Benlysta | $18 |
| Ucb | Meals · 2025-05-22 | Bimzelx | $26 |
| Amgen | Meals · 2025-05-13 | Evenity | $20 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $15 |
| Lilly USA | Meals · 2025-04-29 | Taltz | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-28 | Saphnelo | $19 |
| GlaxoSmithKline | Meals · 2025-04-24 | Benlysta | $20 |
| Amgen | Meals · 2025-04-24 | Otezla | $6 |
| Amgen | Meals · 2025-04-24 | Krystexxa | $110 |
| Ucb | Meals · 2025-04-22 | Bimzelx | $13 |
| GlaxoSmithKline | Meals · 2025-04-18 | Benlysta | $20 |
| Alexion Pharmaceuticals | Meals · 2025-04-17 | Strensiq | $23 |
| Novartis Pharmaceuticals | Meals · 2025-04-07 | Cosentyx | $16 |
| Radius Health | Meals · 2025-04-02 | Tymlos | $23 |
| Amgen | Meals · 2025-03-28 | Tavneos | $17 |
| Pfizer | Meals · 2025-03-25 | Xeljanz | $26 |
| GlaxoSmithKline | Meals · 2025-03-24 | Benlysta | $24 |
| Amgen | Meals · 2025-03-20 | Krystexxa | $12 |
| Amgen | Meals · 2025-03-18 | Evenity | $25 |
| GlaxoSmithKline | Meals · 2025-03-13 | Benlysta | $16 |
| Amgen | Meals · 2025-03-13 | Krystexxa | $10 |
| Ucb | Meals · 2025-03-11 | Bimzelx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-03-10 | Cosentyx | $14 |
| ANI Pharmaceuticals | Meals · 2025-03-08 | Purified Cortrophin Gel | $14 |
| Merz North America | Meals · 2025-03-05 | None | $17 |
| Janssen Biotech | Meals · 2025-03-04 | Tremfya | $6 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-04 | Ofev | $27 |
| Amgen | Meals · 2025-03-04 | Krystexxa | $10 |
| GlaxoSmithKline | Meals · 2025-02-18 | Benlysta | $22 |
| Lilly USA | Meals · 2025-02-13 | Taltz | $24 |
| Pfizer | Meals · 2025-02-06 | Xeljanz | $24 |
| Amgen | Meals · 2025-02-04 | Krystexxa | $18 |
| Celltrion USA | Meals · 2025-01-30 | Vegzelma | $24 |
| Janssen Biotech | Meals · 2025-01-29 | Tremfya | $22 |
| Amgen | Meals · 2025-01-27 | Krystexxa | $31 |
| Amgen | Meals · 2025-01-24 | Otezla | $16 |
| ANI Pharmaceuticals | Meals · 2025-01-24 | Purified Cortrophin Gel | $17 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $121 |
| Alexion Pharmaceuticals | Meals · 2025-01-22 | Strensiq | $26 |
| GlaxoSmithKline | Meals · 2025-01-14 | Benlysta | $30 |
| Pfizer | Meals · 2025-01-14 | Xeljanz | $17 |
| Fidia Pharma USA | Meals · 2025-01-08 | Hymovis | $22 |
| Novartis Pharmaceuticals | Meals · 2025-01-07 | Cosentyx | $28 |
| Ucb | Meals · 2025-01-07 | Bimzelx | $26 |
| Amgen | Meals · 2025-01-02 | Krystexxa | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $3,909
| Amgen | Krystexxa | $652 | 37 payments
|
| Janssen Biotech | Tremfya | $600 | 32 payments
|
| Abbvie | Rinvoq | $550 | 22 payments
|
| Ucb | Bimzelx | $477 | 20 payments
|
| Mallinckrodt Hospital Products | Acthar | $376 | 11 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $368 | 19 payments
|
| GlaxoSmithKline | Benlysta | $247 | 10 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $210 | 14 payments
|
| Pfizer | Xeljanz | $136 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $90 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $71 | 4 payments
|
| Aurinia Pharma U.S. | Lupkynis | $46 | 2 payments
|
| Radius Health | Tymlos | $32 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $28 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $26 | 1 payment
|
2023: $3,085
| Ucb | Cimzia | $636 | 28 payments
|
| Janssen Biotech | Tremfya | $466 | 22 payments
|
| Amgen | Enbrel | $418 | 12 payments
|
| Abbvie | Rinvoq | $333 | 12 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $330 | 6 payments
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $210 | 10 payments
|
| Aurinia Pharma U.S. | Lupkynis | $141 | 1 payment
|
| GlaxoSmithKline | Benlysta | $128 | 6 payments
|
| Exact Sciences | Cologuard Collection Kit | $95 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $57 | 3 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $54 | 3 payments
|
| Genzyme | Kevzara | $50 | 1 payment
|
| Pfizer | Xeljanz | $42 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $37 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $29 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $23 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $20 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
2022: $1,545
| Janssen Scientific Affairs | Tremfya | $403 | 3 payments
|
| Ucb | Cimzia | $287 | 15 payments
|
| Amgen | Enbrel | $261 | 11 payments
|
| Horizon Therapeutics plc | Krystexxa | $198 | 8 payments
|
| Janssen Biotech | Tremfya | $159 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $85 | 4 payments
|
| GlaxoSmithKline | Benlysta | $42 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $38 | 2 payments
|
| Abbvie | Rinvoq | $34 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $22 | 1 payment
|
| Pfizer | Xeljanz | $16 | 1 payment
|
2021: $849
| Amgen | Enbrel | $234 | 11 payments
|
| Horizon Therapeutics plc | Krystexxa | $150 | 4 payments
|
| Radius Health | Tymlos | $125 | 1 payment
|
| Ucb | Cimzia | $96 | 4 payments
|
| Janssen Biotech | Tremfya | $52 | 2 payments
|
| GlaxoSmithKline | Benlysta | $49 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $46 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $26 | 1 payment
|
| AbbVie | Rinvoq | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $18 | 1 payment
|
| Janssen Scientific Affairs | Remicade | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Orencia | $16 | 1 payment
|
2020: $87
| Amgen | Enbrel | $49 | 2 payments
|
| GlaxoSmithKline | Benlysta | $38 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 10.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1508150590
- Licence
- CA 147880
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X); Federal specialty code 207RG0300X (207RG0300X)
- Mailing address
- 1030 E El Camino Real # 151, Sunnyvale, CA, 94087
- NPI first listed
- 2011-06-07
- NPI last updated
- 2022-07-21
- NPI record certified
- 2020-06-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2500 Grant Rd, Mountain View, CA, 94040 · 1150 Tilton Dr, Sunnyvale, CA, 94087